Skip to main content
Log in

The control of 5-hydroxytryptamine and dopamine synthesis in the brain: A theoretical approach

  • Published:
Journal of Inherited Metabolic Disease

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Summary

The transport of the eight amino acids (phenylalanine, tyrosine, tryptophan, valine, leucine, isoleucine, histidine and methionine) using the large neutral amino acid transporter of the blood-brain barrier (BBB) has been calculated using published kinetic data. The fate of the amino acids has been followed from blood to interstitial space, to cell and through metabolism which included, for tyrosine and tryptophan, the hydroxylases. The system was analysed in terms of flux control coefficients. Since the summation theorem did not hold, the system clearly behaved as a non-homogeneous system. At physiological levels of these eight amino acids, the largest contribution to the control of the flux of tyrosine is given by the hydroxylase step, followed by the diffusional component of the transport across the BBB. For tryptophan it is the hydroxylase step, followed by the carrier-mediated transport across the BBB. For the other amino acids it is the metabolism, followed by the diffusional component of the BBB transport.

These parameters for tyrosine and tryptophan were determined at increased levels of blood phenylalanine, tyrosine or histidine. The flux through tryptophan hydroxylase can be affected by high blood levels of tyrosine and histidine to values also observed in hyperphenylalaninaemia. Since hypertyrosinaemia (type II) and hyperhistidinaemia are not associated with mental retardation, it is concluded that interference with transport across the BBB of tyrosine and tryptophan, as well as the flux through tryptophan hydroxylase leading to the synthesis of 5-hydroxytryptamine, do not contribute to the cause of permanent brain dysfunction in hyperphenylalaninaemia.

It can be calculated that addition of tyrosine to the diet to raise the blood tyrosine level in phenylketonuria patients may have a beneficial effect for the synthesis of neurotransmitters derived from tyrosine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Buist, N. R. M., Kennaway, N. G. and Fellman, J. H. Tyrosinemia type II: hepatic cytosolic tyrosine transaminase deficiency (the Richner-Hahnart syndrome). In Bickel, H. and Wachtel, U. (eds.).Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 203–235

    Google Scholar 

  • Coulombe, J. T., Kammerer, B. L., Levy, H. L., Hirsch, B. Z. and Scriver, C. R. Histidinemia, Part III. Impact, a prospective study.J. Inher. Metab. Dis. 6 (1983) 58–61

    Google Scholar 

  • Curzon, G. Influence of plasma tryptophan on brain 5HT synthesis and serotogenic activity. In Harker, B., Gabay, S., Issidoris, M. R. and Alivisatos, S. G. A. (eds.)Serotonin. Current Aspects of Neurochemistry and Function, Plenum Press, New York, 1981, pp. 207–219

    Google Scholar 

  • Ehret, M., Gabaille, S., Cash, C. D., Mandel, P. and Maitrè, M. Regional distribution in rat brain of tryptophan hydroxylase apoenzyme determined by enzyme-linked immunoassay.Neurosci. Lett. 73 (1987) 71–76

    Google Scholar 

  • Giersch, C. Control analysis of metabolic networks. I. Homogeneous functions and the summation theorems for control coefficients.Eur. J. Biochem. 174 (1988) 509–513

    Google Scholar 

  • Heinrich, R. and Rapaport, T. A. A linear steady-state treatment of enzymatic chains. General properties, control and effector strength.Eur. J. Biochem. 42 (1974) 97–105

    Google Scholar 

  • Hjelm, M., Seakins, J., Kitney, R. and Holmes, A. In Bickel, H. and Wachtel, U. (eds.)Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 51–66

    Google Scholar 

  • Hofmeyer, J. H., Kacser, H. and Van der Merwe, K. J. Metabolic control analysis of moiety-conserved cycles.Eur. J. Biochem. 155 (1986) 631–641

    Google Scholar 

  • Hommes, F. A. The role of the blood-brain barrier in the aetiology of permanent brain dysfunction in hyperphenylalaninaemia.J. Inher. Metab. Dis. 12 (1989) 41–46

    Google Scholar 

  • Kacser, H. and Burns, J. A. In Davies, D. D. (ed.)Rate Control of Biological Processes, Cambridge University Press, London, 1973, pp. 65–104

    Google Scholar 

  • Kacser, H. and Burns, J. A. Molecular democracy: who shares the controls.Biochem. Soc. Trans. 7 (1979) 1149–1161

    Google Scholar 

  • Koch, R., Gross Friedman, E. and Azen, C. G. Report from the United States collaborative study of children treated for phenylketonuria (PKU). In Bickel, H. and Wachtel, U. (eds.)Inherited Diseases of Amino Acid Metabolism. Recent Progress in the Understanding, Recognition and Management, Thieme Verlag, Stuttgart, 1985, pp. 134–150

    Google Scholar 

  • Krause, U., Halminski, M., McDonald, L., Dembure, P., Salvo, R., Freides, D. and Elsas, L. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model of the study of phenylalanine and brain function in man.J. Clin. Invest. 75 (1985) 40–48

    Google Scholar 

  • Krause, W., Epstein, C., Averbook, A., Dembure, P. and Elsas, L. Phenylalanine alters the mean power frequency of electroencephalograms and plasmal-DOPA in treated patients with phenylketonuria.Pediatr. Res. 20 (1986) 1112–1116

    Google Scholar 

  • Lou, H. C. Large doses of tryptophan and tyrosine as potential therapeutical alternative to dietary phenylalanine restriction in phenylketonuria.Lancet 2 (1985) 150–151

    Google Scholar 

  • Lou, H. C. Increased vigilance and dopamine synthesis effected by large doses of tyrosine in phenylketonuria. In Wurtman, R. J. and Ritter-Walker, E. (eds.)Dietary Phenylalanine and Brain Function, Birkhäuser, Boston, 1988, pp. 254–260

    Google Scholar 

  • Lou, H. C., Güttler, F., Lykkelund, C., Bruhn, P. and Niederwieser, A. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.Eur. J. Pediatr. 144 (1985) 17–20

    Google Scholar 

  • Lou, H. C., Lykkelund, C., Gerdes, A. M., Udesen, H. and Bruhn, P. Increased vigilance and dopamine synthesis by large doses of tyrosine and phenylalanine restriction in phenylketonuria.Acta Paediatr. Scand. 76 (1987) 560–565

    Google Scholar 

  • Lykkelund, C., Nielsen, J. B., Lou, H. C., Rasmussen, V., Gerdes, A. M., Christensen, E. and Güttler, F. Increased neurotransmitter biosynthesis in phenylketonuria by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine.Eur. J. Pediatr. 148 (1988) 238–245

    Google Scholar 

  • Mackay, A. V. P., Davies, P., Dewar, A. J. and Yates, C. M. Regional distribution of enzymes associated with neurotransmission by monoamines, acetycholine and GABA in the human brain.J. Neurochem. 30 (1978) 827–839

    Google Scholar 

  • Morre, M. C. and Wurtman, R. J. Characteristics of synaptosomal tyrosine uptake in various brain regions: effect of other amino acids.Life Sci. 28 (1981) 65–75

    Google Scholar 

  • Nakato, H. and Fusijawa, H. Purification and properties of tryptophan-5-monooxygenase from rat brain stem.Eur. J. Biochem. 122 (1982) 41–47

    Google Scholar 

  • Neckers, L. M. Serotonin turnover and regulation. In Osborn, N. N. (ed.)Biology of Serotonergic Transmission, Wiley, New York, 1982, pp. 139–158

    Google Scholar 

  • Nelson, T. J. and Kaufman, S. Interaction of tyrosine hydroxylase with ribonucleic acid and purification with DNA cellulose on poly(A)-Sepharose affinity chromatography.Arch. Biochem. Biophys. 257 (1987) 69–84

    Google Scholar 

  • Nielsen, J. B. Effect of dietary tryptophan supplement on neurotransmitter metabolism in phenylketonuria. In Wurtman, R. J. and Ritter-Walker, E. (eds.)Dietary Phenylalanine and Brain Function, Birkhäuser, Boston, 1988, pp. 261–267

    Google Scholar 

  • Pardridge, W. M. Kinetics of competitive inhibition of neutral amino acid transport across the blood-brain barrier.J. Neurochem. 29 (1977) 103–108

    Google Scholar 

  • Pardridge, W. M. Brain metabolism: a perspective from the blood-brain barrier.Physiol. Rev. 63 (1983) 1481–1535

    Google Scholar 

  • Pardridge, W. M. and Choi, Th.D. Neutral amino acid transport at the human blood-brain barrier.Fed. Proc. 45 (1986) 2073–2078

    Google Scholar 

  • Pardridge, W. M. and Oldendorf, W. H. Kinetic analysis of blood-brain barrier transport of amino acids.Biochim. Biophys. Acta 410 (1975) 128–136

    Google Scholar 

  • Pratt, O. E. Kinetics of tryptophan transport across the blood-brain barrier.J. Neurol. Trans. Suppl. 15 (1979) 29–42

    Google Scholar 

  • Rosenmann, A., Scriver, C. R., Claw, C. L. and Levy, H. L. Histidinaemia, Part II. Impact, a retrospective study.J. Inher. Metab. Dis. 6 (1983) 54–57

    Google Scholar 

  • Salter, M., Knowles, R. G. and Pogson, C. I. Quantitation of the importance of individual steps in the control of aromatic amino acid metabolism.Biochem. J. 234 (1986) 635–647

    Google Scholar 

  • Sauro, H. M., Small, J. R. and Fell, D. A. Metabolic control and its analysis. Extension to the theory and matrix method.Eur. J. Biochem. 165 (1987) 215–222

    Google Scholar 

  • Scriver, C. R. We mean well: treatment of Mendelian disease.Acta Paediatr. Jpn. 30 (1988) 472–480

    Google Scholar 

  • Scriver, C. R. and Levy, H. L. Histidinaemia, Part I. Reconciling retrospective and prospective findings.J. Inher. Metab. Dis. 6 (1983) 31–53

    Google Scholar 

  • Smith, Q. R., Momma, S., Aoyogi, M. and Rapaport, S. I. Kinetics of neutral amino acid transport across the blood-brain barrier.J. Neurochem. 49 (1987) 1651–1658

    Google Scholar 

  • Tada, K., Tateda, H., Arishima, S., Saksi, K., Kitagawa, T., Aoki, K., Suwa, S., Kawamura, M., Oura, T., Takesada, M., Kuroda, Y., Yamashita, F., Matsuda, I. and Naruse, H. Intellectual development in patients with untreated histidinemia.J. Pediatr. 101 (1982) 562–563

    Google Scholar 

  • Tada, K., Tateda, H., Arishima, S., Saksi, K., Kitagawa, T., Aoki, K., Suwa, S., Kawamura, M., Oura, T., Takesada, M., Kuroda, Y., Yamashita, F., Matsuda, I. and Naruse, H. Followup of a nationwide screening for inborn errors of metabolism in Japan.Eur. J. Pediatr. 142 (1984) 204–207

    Google Scholar 

  • Tong, J. H. and Kaufman, S. Tryptophan hydroxylase: purification and some properties of the enzyme from rabbit hindbrain.J. Biol. Chem. 250 (1975) 4152–4158

    Google Scholar 

  • Udenfriend, S., Zultzman-Nirenberg, P. and Nagatsu, T. Inhibitors of purified beef adrenal tyrosine hydroxylase.Biochem. Pharmacol. 14 (1965) 837–845

    Google Scholar 

  • Voorhees, C. V., Butcher, R. E. and Berry, H. K. Progress in experimental phenylketonuria: a critical review.Neurosci. Behav. Rev. 5 (1980) 177–190

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hommes, F.A., Lee, J.S. The control of 5-hydroxytryptamine and dopamine synthesis in the brain: A theoretical approach. J Inherit Metab Dis 13, 37–57 (1990). https://doi.org/10.1007/BF01799331

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01799331

Keywords

Navigation